The montreal cognitive assessment to screen for cognitive impairment in HIV patients older than 60 years

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 1, 2014, Pages 67-70

  Milanini, Benedetta ^a   Wendelken, Lauren A ^b   Esmaeili Firidouni, Pardis ^b   Chartier, Maggie ^c   Crouch, Pierre Cedric ^d   Valcour, Victor ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c San Francisco Medical Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; cognition disorders; HIV dementia

Indexed keywords

ADULT; AGE; AGED; ARTICLE; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; COGNITIVE DEFECT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; RECEIVER OPERATING CHARACTERISTIC; VIROLOGY;

AGE FACTORS; AGED; AREA UNDER CURVE; COGNITION DISORDERS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84906094680     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000220     Document Type: Article

References (28)

1. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep. 2010;7:69-76.
2. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155:209-216.
3. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-Associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3-16.
4. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-Associated neurocognitive disorders. Neurology. 2007;69: 1789-1799.
5. Clifford DB. HIV-Associated neurocognitive disease continues in the antiretroviral era. Top HIV Med. 2008;16:94-98.
6. Morgan EE, Iudicello JE, Weber E, et al. Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr. 2012;61:341-348.
7. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology. 2004;63:822-827.
8. Becker JT, Lopez OL, Dew MA, et al. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004;18(suppl 1):S11-S18.
9. Valcour VG, Shikuma CM, Watters MR, et al. Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS. 2004;18(suppl 1):S79-S86.
10. Sacktor N, Skolasky R, Selnes OA, et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. JNeurovirol. 2007;13:203-209.
11. Valcour V, Paul R, Chiao S, et al. Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis. 2011;53:836-842.
12. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.
13. Overton ET, Azad TD, Parker N, et al. The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol. 2013;19:109-116.
14. Koski L, Brouillette MJ, Lalonde R, et al. Computerized testing augments pencil-And-paper tasks in measuring HIV-Associated mild cognitive impairment*). HIV Med. 2011;12:472-480.
15. Chan LG, Kandiah N, Chua A. HIV-Associated neurocognitive disorders (HAND) in a South Asian population-contextual application of the 2007 criteria. BMJ Open. 2012. doi: 10.1136/bmjopen2011-000662.
16. Chiao S, Rosen HJ, Nicolas K, et al. Deficits in self-Awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retroviruses. 2013;29:949-956.
17. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. 2nd ed. San Antonio, TX: The Psychological Corporation; 2000.
18. Ruff RM, Parker SB. Gender-And age-specific changes in motor speed and eye-hand coordination in adults: normative values for the Finger Tapping and Grooved Pegboard Tests. Percept Mot Skills. 1993;76: 1219-1230.
19. Weintraub S, Salmon D, Mercaldo N, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009;23:91-101.
20. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(suppl 1):173-176.
21. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-577.
22. Ganasen KA, Fincham D, Smit J, et al. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. J Neurol Sci. 2008;269:62-64.
23. Skinner S, Adewale AJ, DeBlock L, et al. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to anti-retroviral therapy. HIV Med. 2009;10:246-252.
24. Kamminga J, Cysique LA, Lu G, et al. Validity of cognitive screens for HIV-Associated neurocognitive disorder: a systematic review and an informed screen selection guide. Curr HIV/AIDS Rep. 2013;10:342-355.
25. Gunning-Dixon FM, Brickman AM, Cheng JC, et al. Aging of cerebral white matter: a review of MRI findings. Int J Geriatr Psychiatry. 2009;24:109-117.
26. Valcour V, Paul R, Neuhaus J, et al. The effects of age and HIV on neuro-psychological performance. J Int Neuropsychol Soc. 2011;17:190-195.
27. Valcour VG. Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools. Top Antivir Med. 2011;19:175-180.
28. Sacktor N, Lyles RH, Skolasky R, et al. HIV-Associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001;56:257-260.